Medtronic plc
US ˙ NYSE ˙ IE00BTB1Y115

SecurityMDT / Medtronic plc
InstitutionCoreCap Advisors, LLC
Latest Disclosed Ownership2,295 shares
Latest Disclosed Value $ 198,865
CoreCap Advisors, LLC reports 60.76% decrease in ownership of MDT / Medtronic plc

On April 7, 2026 - CoreCap Advisors, LLC filed a 13F-HR form disclosing ownership of 2,295 shares of Medtronic plc (US:MDT) valued at $198,862 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 5,848 shares of Medtronic plc. This represents a change in shares of -60.76% during the quarter. The current value of the position is $178,895 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F MEDTRONIC PLC SHS Stock G5960L103 2,295 -3,553 -60.76 199 -64.71 0.0068
2026-01-13 2025-12-31 13F MEDTRONIC PLC SHS Stock G5960L103 5,848 1,740 42.36 562 43.48 0.0196
2025-10-22 2025-09-30 13F MEDTRONIC PLC SHS Stock G5960L103 4,108 1,583 62.69 391 77.73 0.0142
2025-08-14 2025-06-30 13F MEDTRONIC PLC SHS Stock G5960L103 2,525 -249 -8.98 220 -11.65 0.0089
2025-05-09 2025-03-31 13F MEDTRONIC SHS G5960L103 2,774 530 23.62 249 39.11 0.0110
2025-02-14 2024-12-31 13F MEDTRONIC SHS G5960L103 2,244 322 16.75 179 3.47 0.0082
2024-11-08 2024-09-30 13F MEDTRONIC SHS G5960L103 1,922 -23,710 -92.50 173 -91.42 0.0081
2024-08-08 2024-06-30 13F MEDTRONIC SHS G5960L103 25,632 1,031 4.19 2,017 -5.88 0.2096
2024-08-08 2024-03-31 13F MEDTRONIC SHS G5960L103 24,601 24,601 2,144 0.1136
2024-01-13 2023-06-30 13F MEDTRONIC PLC SHS Stock G5960L103 0 -1,465 -100.00 0 -100.00
2023-02-10 2022-12-31 13F MEDTRONIC PLC SHS Stock G5960L103 1,465 1,465 114 0.0081
2023-02-10 2022-09-30 13F MEDTRONIC PLC SHS Stock G5960L103 0 -1,503 -100.00 0 -100.00
2022-08-11 2022-06-30 13F MEDTRONIC PLC SHS Stock G5960L103 1,503 -920 -37.97 135 -49.81 0.0105
2022-04-29 2022-03-31 13F MEDTRONIC PLC SHS Stock G5960L103 2,423 -4,249 -63.68 269 -61.01 0.0186
2022-02-10 2021-12-31 13F MEDTRONIC PLC SHS Stock G5960L103 6,672 6,672 690 0.0460
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.